Rogers Craig G, Gonzalgo Mark L, Yan Gai, Bastian Patrick J, Chan David Y, Nelson William G, Pavlovich Christian P
The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
J Urol. 2006 Nov;176(5):2280-4. doi: 10.1016/j.juro.2006.07.047.
We evaluated the concordance between post-digital rectal examination and post-prostate biopsy urine samples using conventional methylation specific polymerase chain reaction analysis of 3 gene promoters in patients with suspected or confirmed prostate cancer.
Voided urine specimens were collected from 17 men after 15-second digital rectal examination and again after transrectal ultrasound guided biopsy of the prostate for suspected malignancy or for followup biopsy as part of an expectant management protocol. Urine sediment DNA was isolated and subjected to bisulfite modification. Methylation of GSTP1, EDNRB and APC promoters was determined by conventional methylation specific polymerase chain reaction analysis in post-digital rectal examination and post-biopsy samples, and correlated with clinical information.
Prostate cancer was detected on prostate biopsy in 12 of 17 patients (71%). Promoter methylation was detected in post-digital rectal examination urine specimens for GSTP1 (24%), APC (12%) and EDNRB (66%). Promoter methylation was detected in post-biopsy urine specimens for GSTP1 (18%), APC (18%) and EDNRB (77%). The concordance between post-digital rectal examination and post-biopsy urine samples was 94% for GSTP1 and APC, and 82% for EDNRB. Overall 100% of patients with biopsy proven prostate cancer had at least 1 gene methylated in urine vs 60% of those without evidence of prostate cancer on biopsy.
Gene analysis using conventional methylation specific polymerase chain reaction is a reliable method for detecting abnormal DNA methylation in voided urine samples obtained following digital rectal examination or prostate needle biopsy. The concordance between post-digital rectal examination and post-biopsy urinary samples for promoter methylation is high (82% to 94%), suggesting that urine collected after digital rectal examination may be used for genetic analysis with results similar to those in post-biopsy urine samples.
我们使用传统的甲基化特异性聚合酶链反应分析3个基因启动子,评估了疑似或确诊前列腺癌患者在直肠指检后和前列腺活检后尿液样本之间的一致性。
从17名男性患者中收集排尿后的尿液样本,一次是在进行15秒直肠指检后,另一次是在经直肠超声引导下对前列腺进行活检后,活检目的是怀疑有恶性肿瘤或作为观察等待治疗方案一部分的随访活检。分离尿液沉淀物中的DNA并进行亚硫酸氢盐修饰。通过传统的甲基化特异性聚合酶链反应分析,测定直肠指检后和活检后样本中GSTP1、EDNRB和APC启动子的甲基化情况,并与临床信息相关联。
17例患者中有12例(71%)在前列腺活检中检测到前列腺癌。在直肠指检后的尿液样本中,检测到GSTP1(24%)、APC(12%)和EDNRB(66%)启动子甲基化。在活检后的尿液样本中,检测到GSTP1(18%)、APC(18%)和EDNRB(77%)启动子甲基化。直肠指检后和活检后尿液样本中,GSTP1和APC的一致性为94%,EDNRB为82%。总体而言,活检证实为前列腺癌的患者中100%的尿液中至少有1个基因发生甲基化,而活检无前列腺癌证据的患者中这一比例为60%。
使用传统的甲基化特异性聚合酶链反应进行基因分析,是检测直肠指检或前列腺穿刺活检后获得的排尿尿液样本中异常DNA甲基化的可靠方法。直肠指检后和活检后尿液样本中启动子甲基化的一致性较高(82%至94%),这表明直肠指检后收集的尿液可用于基因分析,结果与活检后尿液样本相似。